1-4 of 4
Haiyan Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma

Jie Jin, Hong Cen, Keshu Zhou, Xiaohong Xu, Fei Li, Tao Wu, Haiyan Yang, Zhen Wang, Zhiming Li, Wenyang Huang, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (20): 4593–4600.
https://doi.org/10.1158/1078-0432.CCR-24-1194
Published: 15 October 2024
View article titled, A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
Open the PDF for A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

Yuqin Song, Quanli Gao, Huilai Zhang, Lei Fan, Jianfeng Zhou, Dehui Zou, Wei Li, Haiyan Yang, Ting Liu, Quanshun Wang, Fangfang Lv, Haiyi Guo, Xia Zhao, Dan Wang, Pei Zhang, Yidi Wang, Lei Wang, Tengfei Liu, Yun Zhang, Zhirong Shen, Jane Huang, Jun Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1147–1156.
https://doi.org/10.1158/1078-0432.CCR-21-2023
Published: 15 March 2022
View article titled, Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Open the PDF for Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis in another window
Includes: Supplementary data
Journal Articles

Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Rebecca Elstrom, Jane Huang, William Novotny, Rachel Wei, Jun Zhu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (16): 4216–4224.
https://doi.org/10.1158/1078-0432.CCR-19-3703
Published: 14 August 2020
View article titled, Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Open the PDF for Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase in another window
Includes: Supplementary data
Journal Articles

A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis

Yao Liu, Fanzheng Meng, Jiabei Wang, Mingyang Liu, Guangchao Yang, Ruipeng Song, Tongsen Zheng, Yingjian Liang, Shugeng Zhang, Dalong Yin, Jizhou Wang, Haiyan Yang, Shangha Pan, Bo Sun, Jihua Han, Jing Sun, Yaliang Lan, Yan Wang, Xirui Liu, Mingxi Zhu, Yifeng Cui, Bo Zhang, Dehai Wu, Shuhang Liang, Yufeng Liu, Xuan Song, Zhaoyang Lu, Jingxuan Yang, Min Li, Lianxin Liu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (17): 5407–5421.
https://doi.org/10.1158/1078-0432.CCR-18-4113
Published: 03 September 2019
View article titled, A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis
Open the PDF for A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis in another window
Includes: Supplementary data